Pan-cancer analysis predict that FAT1 is a therapeutic target and immunotherapy biomarker for multiple cancer types including non-small cell lung cancer
Article in Frontiers in Immunology (May 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (May 2024)
Article in American Journal of Physiology - Cell Physiology (November 2023)
Article in Cells (June 2023)